Keywords: ACKR; atypical chemokine receptor; ADAM; a disintegrin and metalloprotease; [Ca2+]i; intracellular calcium concentration; CTAP-III; connective tissue-activating peptide III; DPP4; dipeptidyl peptidase 4; ERK; extracellular signal-regulated kinase; GAG; gl
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: T2DM; type 2 diabetes; IR; insulin resistance; HbA1c; glycated hemoglobin A1c; GLUT-4; glucose transporter4; GLP-1; glucagon-like peptide-1; DPP4; dipeptidyl peptidase; eGFR; estimated glomerular filtration rate; HF; heart failure; UKPDS; United Kingdom P
Keywords: Acute pancreatitis; Dipeptidyl peptidase-4 inhibitors; Glucagon-like peptide-1 receptor agonists; Incretin-based therapies; Pancreatic cancer; AERS; Adverse Event Reporting System; CI; confidence interval; DCSI; Diabetes Complication Severity Index; DM; d
Keywords: B2M; beta-2-microglobulin; BMI; body mass index; CCL; chemokine (C-C motif) ligand; cDNA; complimentary deoxyribonucleic acid; CXCL16; chemokine (C-X-C motif) ligand 16; DPP4; dipeptidyl-peptidase 4; DXA; dual energy X-ray absorptiometry; g; gravity; Gadd
Keywords: C-IMT; carotid intima-media thickness test; CV; cardiovascular; DPP4; dipeptidyl peptidase-4; DPP4i; DPP4 inhibitors; GLP1; glucagon-like peptide 1; HbA1c; glycated haemoglobin; HF; heart failure; HR; hazard ratio; MACE; major adverse cardiac event; MI;
Keywords: Diabetes; Glucagon; Islets of Langerhans; Hepatic glucose production; T1D; Type 1 diabetes; T2D; type 2 diabetes; GLP1; glucagon-like peptide 1; DPP4; Dipeptidyl peptidase-4; GR KO mice; glucagon receptor knock out mice; GABA; gamma-aminobutyric acid; PEP
Keywords: SGLT2 inhibitor; DPP4 inhibitor; Canagliflozin; Combination treatment; Glucagon-like peptide-1; aGLP-1; active GLP-1; ANOVA; Analysis of variance; AUC; Area under the curve; CMA; (2S)-2-Cyano-1-[trans-4-(morpholinocarbonyl)cyclohexylamino]acetylpyrrolidin
Keywords: IF; infant formula; HIF; hydrolyzed IF; HM; human milk; CN; casein; WP; whey protein; MS; mass spectrometry; α-LA; α-lactalbumin; β-LG; β-lactoglobulin; eHIF; extensively-hydrolyzed IF; pHIF; partially-hydrolyzed IF; ACE; angiotensin I-converting enzy
Keywords: ACU; azocasein unit; ALP1; alkaline protease 1; CCD; central composite design; DH; degree of hydrolysis; DPP4; dipeptidyl peptidase 4; DPP5; dipeptidyl peptidase 5; DTT; dithiothreitol; h; concentration of free amino groups; htot; maximum concentration of
Keywords: LNCaP; PSA; PC-3; E-cadherin; DPP4; Metastasis; Proliferation
Keywords: ADAM; a disintegrin and metalloprotease; bref A; brefeldin A; DPP4; Dipeptidyl peptidase 4; sDPP4; soluble dipeptidyl peptidase 4; MMP; matrix metalloprotease; SMC; human vascular smooth muscle cell; TACE; tumor necrosis factor α converting enzyme; CD26/
Evaluation of the association of single nucleotide polymorphisms in DDP4 and CDK5RAP2 genes with rheumatoid arthritis susceptibility in Iranian population
Keywords: RA; rheumatoid arthritis; SNP; single nucleotide polymorphism; GWAS; genome-wide association study; HLA; human leukocyte antigen; DPP4; dipeptidyl peptidase-4; CD26; cluster of differentiation 26; CDK-5; Cyclin-dependent kinase 5; CDK5RAP2; Cyclin-depende
A role for Glucagon-Like Peptide-1 in the regulation of β-cell autophagy
Keywords: Akt; protein kinase B; Ambra1; Autophagy And Beclin 1 Regulator 1; AMPK; 5â² AMP-activated protein kinase; Atg; autophagy related proteins; CAMKK; Ca2+/calmodulin-dependent protein kinase kinase; DFCP1; double FYVE-containing protein 1; DPP4; dipeptidyl
Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
Keywords: MERS-CoV; Middle East respiratory syndrome coronavirus; DPP4; Dipeptidyl peptidase 4; RBD; Receptor binding domain; ORF; Open reading frame; Ad5/MERS; Adenovirus 5 expressing MERS-CoV spike protein; MERS-CoV; Vaccine; Adenovirus 5; Th1; Th2; Heterologous
Human gene expression microarray analysis of the HPV 6bE7-HaCaT stable cell line
Keywords: HPV; Human papillomavirus; SLE; Systemic lupus erythematosus; GO; Gene Ontology; KEGG; Kyoto Encyclopedia of Genes and Genomes; DAPI; 4, 6-diamidino-2-phenylindole; H4-K20; Histone H4 lysine 20; qRT-PCR; Quantitative real-time PCR; PCR; polymerase chain r
Constitutive DPP4 activity, inflammation, and microvascular reactivity in subjects with excess body weight and without diabetes
Keywords: ADA; American Diabetes Association; AUC; area uder the curve; BMI; body mass index; CD26; cluster of differentiation 26; DPP4; dipeptidyl peptidase 4; EDTA; ethylenediamine tetraacetic acid; FPG; fasting plasma glucose; GIP; glucose-dependent insulinotrop
Oxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in China
Keywords: BMI; body mass index; BDNF; brain-derived neurotrophic factor; CRP; C-reactive protein; CREB; cAMP response element binding protein; DPP4; dipeptidyl peptidase-4; DBR; DPP4 activity to BDNF ratio; IL-6; interleukin 6; MCI; mild cognitive impairment; MoCA;
Dipeptidyl peptidase-4 impairs insulin signaling and promotes lipid accumulation in hepatocytes
Keywords: DPP4; Liver; Insulin signaling; Lipid metabolism; Insulin resistance;
Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus
Keywords: Animal model; Coronavirus (CoV); Emerging pathogen; Middle East respiratory syndrome (MERS); Reservoir; BSL; biosafety level; DPP4; dipeptidyl peptidase-4; FDA; Food and Drug Administration; HCoV; human coronaviruses; hDPP4; human dipeptidyl peptidase-4;
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Keywords: CD36; DPP4; GLP-1; Insulin resistance; NAFLD; PPARγ; Ad; adenovirus; Akt; Akt serine-threonine protein kinase; ALT; alanine aminotransferase; ApoB; apolipoprotein B; AST; aspartate aminotransferase; BAT; brown adipose tissue; CD36; fatty acid transloca
KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes
Keywords: DPP4; KLK5; PBMC; T2DM; Th17 cells;
ReviewMechanotransduction pulls the strings of matrix degradation at invadosome
Keywords: BM; basement membrane; ECM; extracellular matrix; MMP; matrix metalloproteinases; H+; Â hydrogen ion; Na+; Â sodium ion; VGSC; voltage gated sodium channels; NHE-1; Na+/H+ exchanger 1; DPP4; dipeptidyl-peptidase; FAPa; fibroblasts activation protein a; EG
Unique binding mode of Evogliptin with human dipeptidyl peptidase IV
Keywords: Dipeptidyl peptidase IV; DPP4; Evogliptin; Diabetes; Inhibitor; Complex structure; DPP4; dipeptidyl peptidase-IV; GLP-1; glucagon-like peptide-1; PDB; protein data bank; RMSD; root-mean-square deviation;
Association between DPP4 gene polymorphism and serum lipid levels in Chinese type 2 diabetes individuals
Keywords: DPP4; Polymorphism; Serum lipid levels; Type 2 diabetes;
Rôle du glucagon dans la physiopathologie et le traitement du diabète
Keywords: Diabète; glucagon; production hépatique de glucose; antagonistes du glucagon et de son récepteur; GLP-1 - DPP4; Diabetes; glucagon; hepatic glucose production; glucagon receptor antagonists; GLP-1; DPP4;
Reduced DPP4 activity improves insulin signaling in primary human adipocytes
Keywords: DPP4; siRNA-mediated silencing; DPP4 inhibition; Primary human adipocytes; Insulin signaling
Enhancing T cell therapy by overcoming the immunosuppressive tumor microenvironment
Keywords: ACT; adoptive T cell therapy; TLS; tertiary lymphoid structures; MDSC; myeloid derived-supressor cells; Tfh; T follicular helper; NSCLC; non-small cell lung cancer; MSR; mesoporous silica rods; PSC; pancreatic stellate cells; TIL; tumor-infiltrating lymph
GPR40 agonists for the treatment of type 2 diabetes mellitus: The biological characteristics and the chemical space
Keywords: GPR40; G protein-coupled receptor 40; FFA1; free fatty acid receptor 1; PK; pharmacokinetic; GSIS; glucose-stimulated insulin secretion; T2DM; type 2 diabetes mellitus; IDF; International Diabetes Federation; GLP-1; glucagon-like peptide1; GIP; gastric in
Fibroblast activation protein (FAP) as a novel metabolic target
Keywords: FAP; FGF21; DPP4; Metabolic regulation; Obesity; Diabetes;
Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors
Keywords: ALP; alkaline phosphatase,; APN(R); adiponectin (receptor); BMD; bone mineral density; Coll1; collagen type 1; CXCR4; C-X-C chemokine receptor 4; DPP4; dipeptidyl peptidase 4 (CD26: cluster of differentiation 26); GLP-1/2; glucagon-like peptide 1/2; GIP;
Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function
Keywords: DPP4; Incretin; GLP-1; Cardiometabolic disease; Diabetes
Transcriptomic analysis of Rongchang pig brains and livers
Keywords: RNA-seq; RNA sequencing; DEGs; differentially expressed genes; NMS; neuromedin S; MSH; melanocyte-stimulating hormone; ECLP; extracorporeal liver perfusion; SAGE; serial analysis of gene expression; IGFBPs; insulin-like growth factor binding proteins; qRT
DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY
Keywords: NPY; Anxiety; Stress; Fear; CD26; DPP4;
A de novo 2.3Â Mb deletion in 2q24.2q24.3 in a 20-month-old developmentally delayed girl
Keywords: aCGH; array comparative genomic hybridization; DPP4; dipeptidyl-peptidase 4; EEG; electroencephalography; FAP; fibroblast activation protein alpha; FIGN; fidgetin; FISH; fluorescence in situ hybridization; GCA; granalcin; GCG; glucagon; IFIH1; interferon
Establishment of a selective evaluation method for DPP4 inhibitors based on recombinant human DPP8 and DPP9 proteins
Keywords: DPP4; DPP8; DPP9; Inhibitor; Selective evaluation method
Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
Keywords: DPP4; Smooth muscle cells; Proliferation; Inflammation; Adipokines; Atherosclerosis;
Adipokines – removing road blocks to obesity and diabetes therapy
Keywords: Adipokines; Obesity; Type 2 diabetes; Road blocks; Therapeutic compounds; Leptin; Adiponectin; DPP4; Vaspin; Nampt/visfatin; Nesfatin-1; Apelin; BMP7
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs
Keywords: Fibroblast; Dipeptidyl peptidase; Protease substrates; Protease activity; Liver disease; Fibrosis; Biomarker; ALD; alcoholic liver disease; AMC; amino-4-methylcoumarin; DPP4; dipeptidyl peptidase 4; DMSO; dimethyl sulfoxide; EDTA; ethylene diamine tetra a
ReviewAn emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease
Keywords: DPP4; CD26; Atherosclerosis; Type 2 diabetes; Inflammation; Ab; antibody; ADA; adenosine deaminase; APCs; antigen-presenting cells; BNP; B-type natriuretic peptide; CCL; chemokine (C-C motif) ligand; DPP4; dipeptidase 4; ECM; extracellular matrix; eNOS; e
A Genetic Screen Identifies Interferon-α Effector Genes Required to Suppress Hepatitis C Virus Replication
Keywords: Treatment; Gene Regulation; Virology; Mechanism; ALG10; asparagine-linked glycosylation 10 homolog (yeast, α-1,2-glucosyltransferase); DENV; dengue virus; DPP4; dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2); HCV; hepatitis C vir
Incretins: What is known, new and controversial in 2013?
Keywords: Incretins; Autonomic nervous system; DPP4; Heart; GIPIncretines; Système nerveux autonome; DPP4; Cœur; GIP
Potential of incretin-based therapies for non-alcoholic fatty liver disease
Keywords: Glucagon like peptide-1; GLP-1; Exenatide; DPP4; Hepatic steatosis; NAFLD; Fatty liver; AMP kinase; GLP-1 receptor; Gliptin; Obesity
Influence of cloning by chromatin transfer on placental gene expression at Day 45 of pregnancy in cattle
Keywords: Microarray; IVF; Imprinted; Invasiveness; CKDN1C; DPP4
Dipeptidyl peptidase-4 inhibitor with β-amino amide scaffold: Synthesis, SAR and biological evaluation
Keywords: Diabetes; DPP4; GLP-1; β-Amino amide;
Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors
Keywords: DPP; dipeptidyl peptidase; ADA; adenosine deaminase; Gly-Pro-4-Me-β-NA; glycyl-prolyl-4-methoxy-β-naphthylamide; Gly-Pro-AMC; glycyl-prolyl-7-amino-4-methylcoumarin; Gly-Pro-pNA; glycyl-prolyl-para-nitroanilide; CD26; DPP4; DPPIV inhibitors; Method vali
Liquid chromatography and tandem mass spectrometry method for the quantitative determination of saxagliptin and its major pharmacologically active 5-monohydroxy metabolite in human plasma: Method validation and overcoming specific and non-specific binding
Keywords: Antidiabetic agent; Onglyzaâ¢; Saxagliptin; BMS-477118; 5-Hydroxy saxagliptin metabolite; Dipeptide-peptidase; DPP4; LC-MS/MS; Liquid chromatography-tandem mass spectrometry; Diastereomer; Protein precipitation; Human plasma; Cross-validation;
Dipeptidyl peptidase IV (DPP4)-deficiency attenuates diet-induced obesity in rats: Possible implications for the hypothalamic neuropeptidergic system
Keywords: CD26; DPP4; Rats; Incretins; NPY; PYY; Leptin; Obesity
Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay
Keywords: AD; Alzheimer's disease; AF; amniotic fluid; CEL; bile salt-activated lipase; CN; chromosomally normal; CPA1; carboxypeptidase 1; DPP4; dipeptidyl peptidase 4; DS; Down syndrome; iSRM; intelligent SRM; MMP2; matrix metalloproteinase-2; MUC13; mucin-13; SR
Research ArticleGlucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
Keywords: GLP-1; glucagon like peptide-1; DPP4; dipeptidyl peptidase 4; DPP4; DPP4-deficient rats; AMPK; cAMP activated kinase; Ad-DN-AMPK; AMPK adenovirus-dominant negative; GLP-1R; GLP-1 receptor; PEPCK; phosphoenol pyruvate carboxykinase; G6P; glucose-6-phosphat
Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes
Keywords: DPP4; Azolopyrimidines; GLP-1; SAR;